|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01558 HEC CJ PHARM
Nominal 
9.980 -0.040 (-0.399%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 3,617,986 | 6.462% | 3,398,369 | 3,169,613 | 2,858,808 | 2,489,661 |
| Land & other Lease Assets | 345,585 | 1.032% | 342,055 | 349,152 | 357,747 | 346,045 |
| Intangible Assets | 2,503,625 | -2.417% | 2,565,626 | 2,920,646 | 3,347,886 | 2,785,487 |
| Interests in Asso. & JCEs | 25,464 | 102.561% | 12,571 | 0 | 0 | 0 |
| Other Non-current Assets | 903,152 | 142.358% | 372,652 | 436,369 | 1,919,764 | 675,964 |
| 7,395,812 | 10.529% | 6,691,273 | 6,875,780 | 8,484,205 | 6,297,157 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 645,929 | 57.910% | 409,050 | 315,027 | 279,696 | 378,268 | |
| Trade Receivables | 2,103,683 | 1.499% | 2,072,611 | 1,005,817 | 479,041 | 460,509 | |
| Cash & Bank Balances | 1,403,777 | -16.163% | 1,674,413 | 923,543 | 1,131,121 | 2,044,967 | |
| Other Current Assets | 880,014 | -53.610% | 1,896,982 | 457,313 | 167,518 | 380,366 | |
| Assets Held for Sale | 0 | -- | 0 | 2,312,320 | 0 | 0 | |
| 5,033,403 | -16.845% | 6,053,056 | 5,014,020 | 2,057,376 | 3,264,110 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 177,286 | -11.396% | 200,088 | 167,387 | 115,322 | 239,551 | ||
| S-T Debt & Leases | 1,335,029 | -42.453% | 2,319,877 | 3,130,306 | 48,477 | 2,820,804 | ||
| Other Current Liabilities | 1,328,216 | -26.709% | 1,812,255 | 1,643,088 | 1,074,265 | 1,100,858 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 2,840,531 | -34.432% | 4,332,220 | 4,940,781 | 1,238,064 | 4,161,213 | |||
| Net Current Assets | 2,192,872 | 27.431% | 1,720,836 | 73,239 | 819,312 | (897,103) | ||
| Total Assets Less Current Liabilities | 9,588,684 | 13.987% | 8,412,109 | 6,949,019 | 9,303,517 | 5,400,054 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 899,806 | 210.866% | 289,451 | 691,529 | 3,145,025 | 189,853 | |||
| Other Non-current Liabilities | 180,682 | -3.453% | 187,145 | 187,489 | 137,730 | 106,542 | |||
| 1,080,488 | 126.709% | 476,596 | 879,018 | 3,282,755 | 296,395 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 879,968 | 0.000% | 879,968 | 879,968 | 879,968 | 879,968 | ||||
| Reserves | 7,628,228 | 8.117% | 7,055,545 | 5,004,916 | 4,928,313 | 4,011,135 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 8,508,196 | 7.217% | 7,935,513 | 5,884,884 | 5,808,281 | 4,891,103 | ||||
| Non-controlling Interests | 0 | -- | 0 | 185,117 | 212,481 | 212,556 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 8,508,196 | 7.217% | 7,935,513 | 6,070,001 | 6,020,762 | 5,103,659 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 1,995,174 | 1,876,199 | 2,121,064 | 2,201,644 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 03/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 482,712 |
| %Change | -75.775% |
| EPS / (LPS) | RMB 0.550 |
| NBV Per Share (¥) | RMB 9.669 |